Cargando…
Tumour-associated macrophages heterogeneity drives resistance to clinical therapy
Tumour-associated macrophages (TAMs) constitute a plastic and heterogeneous cell population of the tumour microenvironment (TME) that can account for up to 50% of solid tumours. TAMs heterogeneous are associated with different cancer types and stages, different stimulation of bioactive molecules and...
Autores principales: | Guo, Shuangshuang, Chen, Xiaojing, Guo, Chuhong, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884773/ https://www.ncbi.nlm.nih.gov/pubmed/35400355 http://dx.doi.org/10.1017/erm.2022.8 |
Ejemplares similares
-
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
por: Agirre-Lizaso, Aloña, et al.
Publicado: (2023) -
Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma
por: Pires-Afonso, Yolanda, et al.
Publicado: (2020) -
Metabolism drives macrophage heterogeneity in the tumor microenvironment
por: Li, Shasha, et al.
Publicado: (2022) -
Macrophages heterogeneity in atherosclerosis – implications for therapy
por: Wilson, Heather M
Publicado: (2010) -
Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies
por: Andrade, Joana Reis, et al.
Publicado: (2023)